Dec 04, 2019 / 02:00PM GMT
Matthew Oliver O'Brien - Piper Jaffray Companies, Research Division - MD and Senior Research Analyst
All right. We'll probably get started. Good morning, I'm Matt O'Brien, I cover medtech. We've got the Insulet team up next. Thanks so much for coming down and making it down. And I know there's a lot snowfall making it (inaudible) here. From the company we have Bret, who is the Chief (inaudible) Officer and (inaudible) Chief Financial Officer in the audience (inaudible) Deb and Michael. So we start on the third quarter. Outstanding (inaudible) on that. MDI patient population. We're estimating, just kind of guessing that you have about 70,000 MDI patients at this point. (inaudible) from the Omnipod. There's about 2.75
(technical difficulty)
Wayde D. McMillan - Insulet Corporation - Executive VP,CFO & Treasurer
Thank you.
Questions and Answers:
Matthew Oliver O'Brien - Piper Jaffray Companies, Research Division - MD and Senior Research AnalystAll right. So we're all
Trustpilot
